Delivery Order SPE2DB22D1106-SPE2DB25FFDY6
- Not listed
- The Defense Logistics Agency awarded a $12,054.36 delivery order to AmerisourceBergen Drug Corp for Trulicity 4.5 mg/0.5 ml pen injectors on July 24, 2025, with completion scheduled for July 25, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and specifies performance at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a $4,544.83 delivery order to AmerisourceBergen Drug Corp for Trulicity 3 mg/0.5 ml pen injectors on July 22, 2025, with completion scheduled for July 23, 2025. This competitively awarded, firm fixed price contract carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Trulicity is a diabetes medication commonly supplied through federal pharmaceutical procurement channels to support military and...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,442.85 for Trulicity 1.5 mg/0.5 ml pen injectors on July 25, 2025, with an ultimate completion date of July 28, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Trulicity is a prescription diabetes medication commonly used to support military and veteran...
- The Defense Logistics Agency (DLA) awarded a $1,248.04 delivery order to AmerisourceBergen Drug Corp for Trulicity 1.5 mg/0.5 mL pen injectors on August 5, 2025, with a completion date of August 6, 2025. This firm fixed-price contract was competitively awarded without a set-aside designation and is being performed at the awardee's facility in Conshohocken, Pennsylvania. The delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a delivery order valued at $2,593.82 to AmerisourceBergen Drug Corp for Trulicity 1.5 mg/0.5 ml pen injectors on July 22, 2025, with an ultimate completion date of July 23, 2025. This non-competitive, firm fixed-price delivery order was issued without a set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Trulicity is a diabetes medication used to improve blood sugar control in patients with type 2...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $1,801.80 for Trulicity 1.5 mg/0.5 ml pen injectors, with an ultimate completion date of July 25, 2025. This is a firm fixed price, non-set-aside delivery order issued under a competitive procurement process. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is a child contract under AmerisourceBergen's broader Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pen injections in 0.5 ml doses, valued at $10,714.36. This is a firm fixed-price delivery order with an ultimate completion date of July 29, 2025, with performance taking place at the vendor's facility in Conshohocken, Pennsylvania. The contract was competitively awarded without set-aside designation, reflecting AmerisourceBergen's established...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,041.04 to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Trulicity 1.5 mg/0.5 mL pen injectors. The contract was competitively awarded with no set-aside designation and carries a firm fixed price structure, with an ultimate completion date of July 30, 2025. AmerisourceBergen will perform this work from its corporate office in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $10,343.94 to AmerisourceBergen Drug Corp for the supply of Trulicity 3 mg/0.5 ml pens on August 1, 2025, with an ultimate completion date of August 4, 2025. This firm fixed price delivery order was competitively awarded without set-aside restrictions and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Trulicity is a brand-name diabetes medication widely used in federal healthcare systems, including...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $1,000.54 for Trulicity 1.5 mg/0.5 ml pens on August 5, 2025, with completion scheduled for August 6, 2025. This firm fixed-price delivery order was competitively awarded without set-aside provisions and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Trulicity is a diabetes medication commonly utilized within military and federal healthcare systems, reflecting...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB25FFDY6Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $10,142.67 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 ml pen injectors on August 18, 2025, with completion expected by August 19, 2025. This firm fixed price delivery order was competitively awarded without set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Trulicity is a diabetes management medication commonly used within the Defense Health Agency's pharmaceutical supply chain to support military beneficiaries and veterans. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion blanket purchase agreement running through December 2026 that serves as the primary pharmaceutical supply vehicle for global military healthcare programs. As one of the nation's largest pharmaceutical distributors, AmerisourceBergen maintains extensive federal contracting relationships supplying brand-name and generic medications, vaccines, and medical devices across multiple therapeutic categories to support military medical readiness and veteran healthcare delivery.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.1k | 8/18/25 |